(5-Bromothiophen-2-yl)methanamine

Catalog No.: 
ACWINZ842
CAS No.: 
612499-04-4
Molecular Formula: 
C5H6BrNS
Molecular Weight: 
192.08
(5-Bromothiophen-2-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$58.00In stockInquiry
5g95%$203.00In stockInquiry
25g95%$731.00In stockInquiry
100g95%$2336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-Bromothiophen-2-yl)methanamine
IUPAC Name(5-bromothiophen-2-yl)methanamine
MDL No.MFCD06213820
Molecular FormulaC5H6BrNS
Molecular Weight192.08
SMILESNCC1=CC=C(Br)S1
InChI KeyRAVKMGSIHFLQJU-UHFFFAOYSA-N
Synonym5-Bromothiophen-2-ylmethylamine | AS-39901 | F2169-1273 | AB00993247-01 | BP-11046 | EN300-51289 | FT-0690700 | SCHEMBL1164031 | 5-BROMO-2-THIOPHENEMETHANAMINE | 4-ISOTHIAZOL-5-YLBENZOICACID | 2-THIOPHENEMETHANAMINE, 5-BROMO- | 5-bromothiophen-2-ylmethyla
CAS No.612499-04-4
PubChem CID23130577

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACWINZ842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMYLB158 route compound structure diagram
    ACMYLB1582160-62-5In Stock
  2. Then
  3. ACWINZ842 route product structure diagram
    ACWINZ842612499-04-4In Stock
Inquiry

2. ACWINZ842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAKU318 route compound structure diagram
    ACXAKU318215183-27-0In Stock
  2. Then
  3. ACWINZ842 route product structure diagram
    ACWINZ842612499-04-4In Stock
Inquiry

3. ACWINZ842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMYLB158 route compound structure diagram
    ACMYLB1582160-62-5In Stock
  2. Then
  3. ACWINZ842 route product structure diagram
    ACWINZ842612499-04-4In Stock
Inquiry

Comments (0)